Latest Insider Transactions at Nuvectis Pharma, Inc. (NVCT)
This section provides a real-time view of insider transactions for Nuvectis Pharma, Inc. (NVCT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Nuvectis Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Nuvectis Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2024
|
James F Oliviero Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+34.16%
|
-
|
|
Jun 13
2024
|
Kenneth Hoberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+22.53%
|
-
|
|
Jun 13
2024
|
Matthew L. Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+26.37%
|
-
|
|
May 14
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,940
+0.06%
|
$11,640
$6.74 P/Share
|
|
May 10
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
2,000
+0.06%
|
$12,000
$6.4 P/Share
|
|
May 10
2024
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Open market or private purchase
|
Direct |
1,113
+0.07%
|
$6,678
$6.32 P/Share
|
|
May 10
2024
|
Enrique Poradosu Chief Science & Business Off |
BUY
Open market or private purchase
|
Direct |
500
+0.03%
|
$3,000
$6.29 P/Share
|
|
Mar 18
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
5,000
+0.15%
|
$50,000
$10.29 P/Share
|
|
Jan 03
2024
|
Shay Shemesh Chief Dev. & Ops. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+8.02%
|
-
|
|
Jan 03
2024
|
Enrique Poradosu Chief Science & Business Off |
BUY
Grant, award, or other acquisition
|
Direct |
130,000
+7.96%
|
-
|
|
Oct 10
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
640
+0.02%
|
$7,040
$11.08 P/Share
|
|
Oct 09
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
830
+0.03%
|
$9,130
$11.19 P/Share
|
|
Oct 06
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
250
+0.01%
|
$2,750
$11.27 P/Share
|
|
Oct 05
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,400
+0.04%
|
$15,400
$11.09 P/Share
|
|
Oct 04
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
1,820
+0.06%
|
$18,200
$10.95 P/Share
|
|
Aug 16
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
115
+0.0%
|
$1,725
$15.15 P/Share
|
|
Aug 15
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
235
+0.01%
|
$3,290
$14.34 P/Share
|
|
Aug 11
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
180
+0.01%
|
$2,520
$14.66 P/Share
|
|
Aug 08
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
120
+0.0%
|
$1,680
$14.83 P/Share
|
|
Jul 31
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
860
+0.03%
|
$11,180
$13.88 P/Share
|
|
Jul 28
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,584
+0.1%
|
$33,592
$13.91 P/Share
|
|
Jul 27
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,556
+0.06%
|
$20,228
$13.98 P/Share
|
|
Jul 26
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.38%
|
$130,000
$13.97 P/Share
|
|
Jul 21
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
2,844
+0.11%
|
$39,816
$14.61 P/Share
|
|
Jul 21
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
225
+0.01%
|
$3,150
$14.85 P/Share
|
|
Jul 20
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,394
+0.21%
|
$75,516
$14.4 P/Share
|
|
Jul 20
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
110
+0.0%
|
$1,650
$15.06 P/Share
|
|
Jul 19
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
200
+0.01%
|
$2,800
$14.33 P/Share
|
|
Jul 19
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,000
+0.31%
|
$112,000
$14.84 P/Share
|
|
Jul 18
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
9,149
+0.36%
|
$128,086
$14.84 P/Share
|
|
Jul 14
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
150
+0.0%
|
$2,250
$15.03 P/Share
|
|
Jul 12
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,285
+0.13%
|
$49,275
$15.09 P/Share
|
|
Jul 11
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
10,000
+0.39%
|
$150,000
$15.36 P/Share
|
|
Jul 07
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
110
+0.0%
|
$1,760
$16.19 P/Share
|
|
Jul 07
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,948
+0.35%
|
$134,220
$15.19 P/Share
|
|
Jul 06
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
320
+0.01%
|
$4,480
$14.88 P/Share
|
|
Jul 06
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
3,179
+0.13%
|
$47,685
$15.01 P/Share
|
|
Jul 05
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,176
+0.05%
|
$17,640
$15.52 P/Share
|
|
Jun 26
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
750
+0.02%
|
$12,000
$16.5 P/Share
|
|
Jun 26
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
16,760
+0.66%
|
$268,160
$16.46 P/Share
|
|
Jun 23
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
73,175
+2.83%
|
$1,243,975
$17.43 P/Share
|
|
Jun 22
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,999
+0.29%
|
$118,983
$17.73 P/Share
|
|
Jun 21
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
6,091
+0.25%
|
$103,547
$17.71 P/Share
|
|
Jun 21
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
500
+0.02%
|
$8,500
$17.88 P/Share
|
|
Jun 16
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
12,700
+0.52%
|
$215,900
$17.75 P/Share
|
|
Jun 16
2023
|
Kenneth Hoberman Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+19.75%
|
-
|
|
Jun 16
2023
|
Matthew L. Kaplan Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+25.08%
|
-
|
|
Jun 16
2023
|
James F Oliviero Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
18,000
+39.28%
|
-
|
|
Jun 15
2023
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
32,124
+0.66%
|
$546,108
$17.63 P/Share
|
|
Jun 08
2023
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
120
+0.0%
|
$2,040
$17.53 P/Share
|